For Fatty Liver Disease

GLP-1 weight loss support for fatty liver.

Physician-reviewed care for the most common chronic liver condition

Non-alcoholic fatty liver disease (NAFLD/MASLD) affects roughly 1 in 4 US adults. Sustained weight loss is the single most effective intervention. GLP-1 medications have shown reductions in liver fat and enzymes in clinical trials of brand-name products. A licensed Puri-affiliated physician can evaluate whether compounded semaglutide or tirzepatide may fit your care plan.

Fatty liver and GLP-1: the practical overview.

Quick summary

Fatty liver and GLP-1: the practical overview.

Fatty liver disease (now called MASLD) is silent, common, and metabolic. The most effective treatment is sustained weight loss. Brand-name GLP-1 medications have shown improvements in liver fat content, enzymes, and in some trials liver histology. Compounded versions are not FDA-approved and have not been studied to the same degree.

Compounded semaglutide starts at $179/mo and compounded tirzepatide starts at $249/mo through Puri. A licensed provider makes the prescribing decision based on your clinical picture, including liver function and any imaging you can share. A prescription is not guaranteed.

1 in 4
US adults
Affected
5-10%
Weight loss
Often improves liver fat
Silent
Most cases
No symptoms early

The Complete Guide

Fatty liver disease and GLP-1 weight loss: what to know

A practical guide for adults with fatty liver disease (NAFLD/MASLD) who want to understand how weight loss and GLP-1 medications fit into a real care plan.

Reviewed by Puri's care team12 minute read

What fatty liver actually is

Non-alcoholic fatty liver disease — recently renamed metabolic dysfunction-associated steatotic liver disease, or MASLD — is the accumulation of fat in the liver of people who do not drink heavily. It is the most common chronic liver condition in the world. Roughly one in four US adults has some degree of it. Most do not know.

There is a spectrum. Simple fatty liver (steatosis) is fat sitting in the liver without inflammation. The next step up is metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH) where the fat is causing inflammation and scarring. If MASH continues unchecked it can progress to fibrosis and eventually cirrhosis. The whole spectrum is silent until it is not, which is part of why screening is increasingly recommended for people with obesity, type 2 diabetes, or metabolic syndrome.

Fatty liver is rarely diagnosed by symptoms because there usually are not any. It is found on imaging (ultrasound, MRI) or suspected from elevated liver enzymes (ALT, AST) on routine bloodwork.

Why GLP-1 medications are relevant for fatty liver

Fatty liver is, fundamentally, a metabolic disease. The liver is processing more fat than it can export, in part because of insulin resistance, in part because of caloric excess, in part because of altered gut hormone signaling. GLP-1 receptor agonists address several of these pieces simultaneously.

Multiple clinical trials of brand-name semaglutide (the active ingredient in Wegovy and Ozempic) and tirzepatide have shown reductions in liver fat content, improvements in liver enzymes, and in some studies improvements in MASH markers on biopsy. The ESSENCE trial of semaglutide in MASH patients reported improvements in liver histology in a meaningful proportion of participants. Tirzepatide trials have shown similar directionally favorable effects.

Compounded versions of these medications have not been studied in fatty liver populations. The available evidence applies to FDA-approved finished products, not compounded formulations. A licensed physician evaluates the prescribing decision based on your individual situation.

What labs and imaging your provider may want

If you have fatty liver or suspect you might, the workup typically includes:

  • Liver enzymes (ALT, AST, GGT, alkaline phosphatase). Elevated ALT is the most common red flag, though normal enzymes do not rule out fatty liver.
  • FIB-4 score. A simple calculation using age, AST, ALT, and platelet count that estimates the likelihood of advanced fibrosis. Many primary care offices now use it routinely.
  • Imaging. Ultrasound is the cheapest. FibroScan / transient elastography is better for assessing fibrosis. MRI-PDFF is the gold standard for fat content.
  • Metabolic panel. Fasting glucose, A1c, lipid panel — fatty liver almost always travels with other metabolic problems.

If you do not have these results, your primary care physician can order them. Bring them to your Puri intake. Related: metabolic syndrome guide and insulin resistance guide.

What helps fatty liver besides medication

The single most effective intervention for fatty liver is weight loss. Even a modest reduction in body weight (5-10%) can produce measurable improvements in liver fat content and enzymes for many patients. GLP-1 medication makes that weight loss easier for many people, but the foundational habits matter regardless of whether you take medication.

  • Reduce added sugar and ultra-processed carbohydrates. Fructose in particular goes straight to the liver and is the food the liver loves to convert into fat.
  • Eliminate alcohol. Alcohol is hepatotoxic and stacks on top of the metabolic stress already present.
  • Mediterranean-style eating. Olive oil, fish, vegetables, and nuts have the strongest evidence for liver health.
  • Strength training and walking. Physical activity improves insulin sensitivity independently of weight loss.
  • Treat the stack. Sleep apnea, type 2 diabetes, and high triglycerides all worsen fatty liver. Fixing one helps fix the others.

How to get started

If you have been told you have fatty liver, or you have elevated liver enzymes and unexplained weight gain, the first step is a conversation with a physician who treats metabolic disease, not just the symptoms.

Ready to start? Complete your assessment. A licensed Puri-affiliated physician will review your medical history, labs, and goals. A prescription is not guaranteed.

Cited sources

Where the evidence comes from.

The research referenced throughout this guide draws from peer-reviewed clinical studies and guidelines published by medical professional societies. The studies describe findings for specific brand-name GLP-1 products. They do not represent promises of individual outcomes, and they do not apply directly to compounded medications.

Where the evidence comes from.

The American Association for the Study of Liver Diseases publishes clinical practice guidance on the diagnosis and management of fatty liver disease.

AASLD Practice Guidance: NAFLD

The ESSENCE trial of semaglutide in MASH patients reported improvements in liver histology and inflammation markers in a meaningful proportion of participants.

PubMed: GLP-1 fatty liver trials

The American Diabetes Association's annual standards of care address the link between type 2 diabetes, metabolic syndrome, and fatty liver disease.

American Diabetes Association

The National Institute of Diabetes and Digestive and Kidney Diseases publishes patient and clinician resources on NAFLD and NASH.

NIDDK: NAFLD & NASH

The US Food and Drug Administration publishes prescribing information for FDA-approved GLP-1 products including indicated uses, dosing, and safety data.

FDA Drug Information

These links are provided for educational reference. Puri is not affiliated with these organizations. GLP-1 medications referenced may not be FDA-approved for the specific condition discussed. Compounded versions are not FDA-approved for any indication. Always talk to your healthcare provider before starting any new medication.

Programs

GLP-1 options available through Puri

Every plan includes a physician review, personalized dosing, provider messaging, and free shipping. A prescription is not guaranteed and requires licensed provider approval.

Most Popular

Compounded Semaglutide

$179/mo
  • Weekly self-injection
  • Compounded (not FDA-approved)
  • Personalized dosing
  • Provider oversight included
  • Free expedited shipping
Get Started

Compounded Tirzepatide

$249/mo
  • Weekly self-injection
  • Dual GLP-1 and GIP activity
  • Compounded (not FDA-approved)
  • Provider oversight included
  • Free expedited shipping
Get Started

Oral GLP-1 Tablets

$249/mo
  • No injections needed
  • Daily oral tablet
  • Compounded (not FDA-approved)
  • Provider oversight included
  • Free shipping
Get Started

Process

How it works

Three simple steps to start your journey

Get Approved
1

Get Approved

Complete a quick online evaluation to determine if treatment is right for you. No payment required upfront.

Get Prescribed
2

Get Prescribed

Once approved, a licensed provider will create a personalized treatment plan tailored to your needs and goals.

Receive Your Rx
3

Receive Your Rx

Your medication will be shipped directly to your door with free expedited delivery in discreet packaging.

FAQ

Common questions about fatty liver and GLP-1

Educational answers, not medical advice.

Satisfaction Guarantee

Care that puts you first.

Personalized support from licensed providers, with a satisfaction guarantee on your first month (terms apply). Individual results vary. Outcomes are not guaranteed.